Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blink Intensive Triple Action is an over-the-counter (OTC) ophthalmic solution designed to provide symptomatic relief for dry eye, irritation, and discomfort. It features a triple-action formulation that lubricates, moisturizes, and protects the ocular surface. The product contains a combination of active and supportive ingredients, including sodium hyaluronate (a viscoelastic lubricant), polyethylene glycol-400 (PEG-400), liposomes (to stabilize the lipid layer of the tear film), and vitamin E. Originally developed by Abbott Medical Optics (AMO), the brand is now part of the Johnson & Johnson Vision portfolio. It is formulated to be compatible with contact lens use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Blink Intensive Triple Action.